First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis


Creative Commons License

Isikdogan A., Turk H., Bilir C., Sendur M., Karabulut B., Artac M., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.33, 2022 (SCI-Expanded, Scopus) identifier